Registered entities
PREVAIL THERAPEUTICS INC.
Reg. No. 1714798United States
Innovation
23 patent families (5 granted) — focus: Chemistry & metallurgy, Human necessities, Physics & computing; filing pace slowing. Cited 2,628 times.
| Year | Filings |
|---|---|
| 2019 | 6 |
| 2020 | 9 |
| 2021 | 9 |
| 2022 | 17 |
| 2023 | 11 |
| 2024 | 10 |
| 2025 | 9 |
| 2026 | 3 |
Investor mix
14 investors on record; lead investors include Orbimed, Pontifax, RA Capital Management, EcoR1; 1 has since exited.
| Investor type | Count | Share |
|---|---|---|
| Venture capital | 5 | 36% |
| Private equity | 2 | 14% |
| Other / undisclosed | 7 | 50% |